NCT05797272View on ClinicalTrials.gov

In-utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses With Bart's Hydrops Fetalis Syndrome

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Haemoglobin Barts Hydrops
Interventions
PROCEDURE

in-utero HSCT

Pregnant women who are diagnosed to have BHFS affected fetuses and opt for continuation of pregnancy will undergo in-utero HSCT.

Trial Locations (1)

Unknown

RECRUITING

The Chinese University of Hong Kong, Shatin

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER